Oxygen homeostasis and cardiovascular disease: A role for HIF? - 18/06/20



pages | 10 |
Iconographies | 4 |
Vidéos | 0 |
Autres | 0 |
Graphical abstract |
Highlights |
• | The oxygen balance control in cardiovascular diseases. |
• | The molecular regulation of HIF-1 in cardiovascular diseases. |
• | The therapeutic significance of HIF-1 in cardiovascular diseases. |
Abstract |
Hypoxia, the decline of tissue oxygen stress, plays a role in mediating cellular processes. Cardiovascular disease, relatively widespread with increased mortality, is closely correlated with oxygen homeostasis regulation. Besides, hypoxia-inducible factor-1(HIF-1) is reported to be a crucial component in regulating systemic hypoxia-induced physiological and pathological modifications like oxidative stress, damage, angiogenesis, vascular remodeling, inflammatory reaction, and metabolic remodeling. In addition, HIF1 controls the movement, proliferation, apoptosis, differentiation and activity of numerous core cells, such as cardiomyocytes, endothelial cells (ECs), smooth muscle cells (SMCs), and macrophages. Here we review the molecular regulation of HIF-1 in cardiovascular diseases, intended to improve therapeutic approaches for clinical diagnoses. Better knowledge of the oxygen balance control and the signal mechanisms involved is important to advance the development of hypoxia-related diseases.
Le texte complet de cet article est disponible en PDF.Abbreviations : HIF-1, ECs, SMCs, PHD, VHL, HRE, VSMCs, iNOS, HO-1, CT-1, ROS, CHIP, VEGF, PIGF, ANGPT1, ANGPT2, VEGFA, FGF, TGF, Efna3, VEGFR, DLL4, FIH, Foxm1, HGF, Ets-1, EPCs, SDF-1, CXCR-4, NOS, MIF, KLF5, ET-1, TRPC, NHE, PASMC, I/R, NADPH, COX, PDK1, BNIP3, CaN–NFAT, MAPK, CHPH, HPH, H2O2, Kv, oxLDL, HUVECs, HIG2, HILPDA, LD, PGE2, Ang II, AGM, HPAEs, APC, Th1, ATF4, M-CSF, HK2, PKM2, mtROS, CKD, EETs, RIP, OPCS, IDO, Arg-1, ADM, IPC, MSC, CPCs, MC-HIF1, CSCs
Keywords : Hypoxia-Inducible factor 1, Cardiovascular diseases, Blood vessels, Macrophages, Atherosclerosis, Myocardial infarction
Plan
Vol 128
Article 110338- août 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?